<DOC>
	<DOCNO>NCT00849888</DOCNO>
	<brief_summary>The study purpose determine thymus tissue culture serum-free ( SF ) solution safe effective treatment atypical typical complete DiGeorge anomaly . [ Funding Source - FDA OOPD ]</brief_summary>
	<brief_title>Serum-Free Thymus Transplantation DiGeorge Anomaly</brief_title>
	<detailed_description>Complete DiGeorge anomaly congenital disorder characterize athymia . Without successful treatment , patient remain immunodeficient usually die age 2 year . In `` typical '' complete DiGeorge subject T cell , thymus transplantation without immunosuppression result diverse T cell development good T cell function . In `` atypical '' complete DiGeorge subject thymus , rash , T cell presumably develop extrathymically , thymus transplantation immunosuppression result diverse T cell development good T cell function . Thus far , thymus transplantation study use thymus cultured fetal bovine serum ( FBS medium ) . This protocol 's purpose determine whether transplanted thymus culture serum free medium safely support thymopoiesis T cell reconstitution FBS medium culture thymus tissue DiGeorge anomaly subject . This protocol include 2 arm : atypical DiGeorge subject receive immunosuppression thymus transplantation ; , typical complete DiGeorge subject receive thymus transplantation without immunosuppression . Serum free medium use would reduce concern animal product exposure include potential exposure bovine spongiform encephalopathy ( BSE ) .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>DiGeorge Syndrome</mesh_term>
	<criteria>Thymus Recipients Inclusion : Complete DiGeorge anomaly diagnosis Must one following : congenital heart disease hypocalcemia require replacement 22q11 10p13 hemizygous CHARGE Atypical Arm : Must , , rash . If rash present , skin biopsy must show T cell . If rash resolve , must &gt; 50/cumm T cell ; &amp; &lt; 50/cumm naive T cell &lt; 5 % total PHA response must &lt; 40000 count per minute ( cpm ) immunosuppression ; , &lt; 75000cpm immunosuppression . PHA test must do 2x CD45RA+CD62L+ CD3+ T cell must &lt; 50/mm3 ; , &lt; 5 % total CD3 . Test must do 2x Typical Arm : PHA response &lt; 20 fold &lt; 5,000cpm Circulating CD3+CD45RA+CD62L+T cell &lt; 50/mm3 &lt; 5 % total T cell 2 test T cell &amp; PHA response must show similar result Biological Mother Inclusion : Must recipient 's biological mother Thymus Recipient Exclusion : Heart surgery &lt; 4 week pretransplant within 3 month posttransplant Rejection surgeon anesthesiologist surgical candidate Lack sufficient muscle tissue accept transplant Medical condition allow undergo biopsy HIV CMV ( &gt; 500 copies/ml blood PCR 2 test ) Ventilator dependence GVHD Maternal T cell &gt; 20 % total T cell Prior immune reconstitution attempt ( e.g. , BMT , prior thymus transplant ) Hypoparathyroidism meet criterion combine thymus/parathyroid transplant &amp; parent desire RSV parainfluenza virus Enterovirus Adenovirus stool Biological Mother Exclusion : Unwillingness sign consent provide blood/buccal sample</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Thymus Transplantation</keyword>
	<keyword>DiGeorge Anomaly</keyword>
	<keyword>Athymia</keyword>
	<keyword>Low T cell number</keyword>
	<keyword>Immunoreconstitution</keyword>
	<keyword>Immunodeficiency</keyword>
</DOC>